Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dittadi

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The International Journal of Biological Markers|January 1, 1990
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fractionM Gion, C Tremolada, R Mione, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre studyM Gion, R Dittadi, A E Leon, et al.
Anticancer Research|September 1, 1993
Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimensR Dittadi, L Catozzi, M Gion, et al.
Tumori|October 31, 1989
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagusM Gion, C Tremolada, R Mione, et al.
Clinical Chemistry|October 1, 1996
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samplesR Dittadi, P Barioli, M Gion, et al.
The International Journal of Biological Markers|October 26, 2005
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational studyA Leon, M Torta, R Dittadi, et al.
Journal of the National Cancer Institute|January 15, 1997
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinomaG Gasparini, M Toi, M Gion, et al.
Breast Cancer Research and Treatment|January 1, 1996
Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parametersA Piffanelli, R Dittadi, L Catozzi, et al.
The Cancer Journal From Scientific American|April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapyG Gasparini, M Toi, R Miceli, et al.
The International Journal of Biological Markers|November 1, 2002
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT)A Paradiso, S Volpe, A Iacobacci, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The International Journal of Biological Markers|January 1, 1990
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fractionM Gion, C Tremolada, R Mione, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre studyM Gion, R Dittadi, A E Leon, et al.
Anticancer Research|September 1, 1993
Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimensR Dittadi, L Catozzi, M Gion, et al.
Tumori|October 31, 1989
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagusM Gion, C Tremolada, R Mione, et al.
Clinical Chemistry|October 1, 1996
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samplesR Dittadi, P Barioli, M Gion, et al.
The International Journal of Biological Markers|October 26, 2005
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational studyA Leon, M Torta, R Dittadi, et al.
Journal of the National Cancer Institute|January 15, 1997
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinomaG Gasparini, M Toi, M Gion, et al.
Breast Cancer Research and Treatment|January 1, 1996
Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parametersA Piffanelli, R Dittadi, L Catozzi, et al.
The Cancer Journal From Scientific American|April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapyG Gasparini, M Toi, R Miceli, et al.
The International Journal of Biological Markers|November 1, 2002
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT)A Paradiso, S Volpe, A Iacobacci, et al.
Pageof 5